BiotechTube

Pneumococcal Vaccine

ApprovedRecruiting
0 watching 0 views this week🔥 Hot
85
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
✓
Phase 2
✓
Phase 3
5
Approved
Indication / Disease

Vaccine

Conditions

Vaccine, Pneumococcal Disease

Trial Timeline

Mar 1, 2026 → Aug 1, 2027

NCT ID
NCT07135453

About Pneumococcal Vaccine

Pneumococcal Vaccine is a approved stage product being developed by Merck for Vaccine. The current trial status is recruiting. This product is registered under clinical trial identifier NCT07135453. Target conditions include Vaccine, Pneumococcal Disease.

Hype Score Breakdown

Clinical
30
Activity
20
Company
10
Novelty
10
Community
12

Clinical Trials (1)

NCT IDPhaseStatus
NCT07135453ApprovedRecruiting

Competing Products

20 competing products in Vaccine

See all competitors
ProductCompanyStageHype Score
AZD1222AstraZenecaPre-clinical
23
Vaxelis™MerckApproved
85
21-valent pneumococcal conjugate vaccineMerckApproved
85
Quadrivalent HPV [Type 6, 11, 16 and 18] L1 Virus-Like Particle VaccineMerckPre-clinical
23
quadrivalent human papillomavirus vaccine + quadrivalent human papillomavirus vaccineMerckPre-clinical
23
Tetanus & Diphtheria booster vaccine (Td) + TwinrixTM [Hepatitis A Inactivated & Hepatitis B (Recombinant) Vaccine] + Dukoral® Traveler's Diarrhea Vaccine (WC/rBS)MerckPre-clinical
23
9-valent human papillomavirus vaccine (Gardasil 9) - 3 doses + 9-valent human papillomavirus vaccine (Gardasil 9) - 2 doses + 9-valent human papillomavirus vaccine (Gardasil 9) - 1 doseMerckPhase 3
77
Gardasil-9MerckApproved
85
Rotarix + RotaTeqMerckPhase 3
77
Human papillomavirus 9-valent vaccine, recombinant + human papillomavirus vaccine, recombinantMerckApproved
85
Seasonal Influenza VaccineNovartisPhase 3
77
Fluad + SalineNovartisApproved
85
Monovalent inactivated influenza vaccineNovartisPhase 2
52
cTIVNovartisPhase 3
77
Monovalent inactivated influenza vaccineNovartisPhase 3
77
Fluad H5N1 Pandemic Influenza VaccineNovartisPhase 2
52
13-valent pneumococcal conjugate vaccine + 7-valent pneumococcal conjugate vaccinePfizerPhase 3
76
13-valent pneumococcal conjugate vaccine + 13-valent pneumococcal conjugate vaccinePfizerPhase 3
76
13vPnC + 23vPSPfizerPhase 3
76
13-valent pneumococcal conjugate vaccine + 13-valent pneumococcal conjugate vaccinePfizerApproved
84

Other Products from Merck

DuleraApproved
85
ImipenemApproved
85
Mavenclad®Approved
85
raltegravir + PlaceboApproved
85
alendronate sodiumApproved
85